Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOSHIN SHAHD in Type 2 Diabetes
NCT06205030Phase 4Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Sep 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
A Phase 4 trial of NOSHIN SHAHD in type 2 diabetes mellitus (T2DM), sponsored by Kerman University of Medical Sciences. Started Sep 2025; status: completed.
02
Drugs
NOSHIN SHAHD
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06205030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06205030.